COVID-19 Recovery And Outcomes: Guide For Arthritis Patients
Essential FAQs on COVID-19 recovery for arthritis patients: risks, hospitalization, outcomes and protective strategies.
People with arthritis, particularly those with autoimmune or inflammatory types, face unique considerations when recovering from COVID-19. While risks of severe outcomes exist, advancing treatments, vaccines and early detection have significantly improved recovery prospects. This guide addresses key questions on hospitalization, mortality and long-term recovery for arthritis patients.
Updated July 29, 2022. News and scientific understanding of COVID-19 continues to evolve rapidly. Information here reflects the latest available data at publication but may change.
Am I More Likely to Have Severe Disease or Be Hospitalized with COVID-19 if I Have Autoimmune or Inflammatory Arthritis?
Patients with rheumatic and musculoskeletal diseases, including autoimmune or inflammatory arthritis, are more likely to experience severe COVID-19 outcomes compared to the general population. However, these risks have decreased over time due to better viral understanding, effective treatment protocols, widespread testing and therapeutic advancements.
Several factors elevate hospitalization risk in these patients:
- Comorbid conditions: CDC data shows ~90% of hospitalized COVID-19 patients had underlying issues like obesity, hypertension, chronic lung disease, diabetes or cardiovascular disease—common in rheumatic patients.
- High-dose corticosteroids: Doses of 10mg or more increase severity risk.
- Age 65+: Older rheumatic patients face heightened hospitalization chances.
Reinfections pose additional risks, particularly for immunocompromised individuals. Protective steps like masking in crowded indoor spaces, staying current on vaccines/boosters and controlling arthritis activity can optimize outcomes.
How Are People with Autoimmune Disease Faring When Hospitalized with COVID-19?
Data on hospitalized rheumatology patients remains limited, but promising trends emerge. A December 2020 Lancet Rheumatology study tracked 8,540 rheumatic patients with COVID-19, comparing January 2020 hospitalizations to April 2020.
Key improvements in the later cohort:
- Lower ICU admission rates
- Reduced mechanical ventilation needs
- Fewer acute kidney injuries
- Less renal replacement therapy
- Decreased mortality
Patients aged 65+ were more prone to hospitalization. These findings indicate declining severe complication rates as pandemic knowledge grew.
Are People with Osteoarthritis More Likely to Be Hospitalized with COVID-19?
Individuals with osteoarthritis (OA) face similar hospitalization risks as the general population. However, OA often coexists with risk amplifiers like diabetes and obesity, indirectly elevating vulnerability.
To mitigate:
- Maintain weight control and blood sugar management.
- Prioritize routine medical care, including telehealth for safety.
Are People with Autoimmune or Inflammatory Arthritis Who Have COVID-19 More Likely to Die?
Limited early data suggested modest increases. A September 2020 Journal of Infection analysis of five studies (2,091 patients) found autoimmune diseases linked to:
- 1.21-fold higher severe COVID-19 risk
- 1.31-fold increased mortality risk
Authors urged caution due to small samples (mostly Chinese studies) and called for larger, high-quality research. Outcomes have since improved with vaccines and treatments.
Key Factors Influencing Recovery in Arthritis Patients
Recovery trajectories vary by arthritis type, comorbidities and interventions. Inflammatory arthritis patients benefit from:
| Factor | Impact on Recovery | Evidence |
|---|---|---|
| Vaccination/Boosters | Prevents severe illness; wanes over time in immunocompromised | Prevented millions of deaths; breakthrough common with variants |
| Early Testing/Treatment | Reduces hospitalization via antivirals like Paxlovid | Best in older/immunocompromised; drug interactions common |
| Arthritis Control | Low disease activity lowers complication risk | Sleep, exercise, anti-inflammatory diet aid management |
| Medication Adjustments | Temporary holds for certain DMARDs/corticosteroids | ACR guidelines; never stop abruptly |
Paxlovid excels for high-risk groups but interacts with many arthritis meds (e.g., corticosteroids). Consult providers promptly.
Protective Measures for Better Outcomes
Beyond vaccines, arthritis patients should:
- Monitor symptoms closely: Test immediately if exposed or symptomatic, especially on immunosuppressants.
- Adhere to ACR guidelines: Pause specific drugs only under guidance during infection.
- Lifestyle optimization: Exercise, sleep and diet reduce inflammation and comorbidities.
- Stay informed: Variants evade immunity; layered prevention essential.
Juvenile Arthritis and COVID-19 Recovery
Children with juvenile arthritis (JA) show no elevated severe outcome risk versus healthy peers, per CARRA registry data (607 patients). Comorbidities and drugs like corticosteroids/rituximab drive risks, not JA itself.
Myocarditis risks are higher from infection than vaccines; JA kids not disproportionately affected. Families should vaccinate and use precautions.
Frequently Asked Questions
Does arthritis medication worsen COVID-19 recovery?
Certain immunosuppressants may require pausing, but don’t adjust without doctor input. ACR provides specific protocols.
Can OA patients expect normal recovery?
Yes, barring comorbidities. Manage weight/diabetes for optimal results.
Are reinfections riskier for rheumatic patients?
Yes, especially immunocompromised. Vaccines, masking and arthritis control help.
What treatments speed recovery?
Antivirals (Paxlovid, remdesivir), monoclonal antibodies; efficacy varies by patient profile.
Should I delay arthritis care during recovery?
No—uncontrolled arthritis worsens outcomes. Use telehealth/safe in-person visits.
Long-Term Outlook and Evolving Data
As of 2023 updates, vaccines/boosters remain cornerstone protections despite variant challenges. Rheumatic patients’ outcomes continue improving with personalized care. Consult rheumatologists for tailored advice amid ongoing evolution.
Maintain vigilance: Comorbidities, not arthritis alone, primarily dictate severity. Proactive management yields best recoveries.
References
- COVID-19 FAQs: Recovery and Outcomes — Arthritis Foundation. 2022-07-29. https://www.arthritis.org/health-wellness/about-arthritis/related-conditions/other-diseases/covid-19-faqs-recovery-and-outcomes
- COVID-19 FAQs: Medications and Treatments — Arthritis Foundation. 2023-01-04. https://www.arthritis.org/health-wellness/about-arthritis/related-conditions/other-diseases/covid-19-faqs-testing
- Coronavirus and Arthritis: What You Need to Know — Arthritis Foundation. N/A. https://www.arthritis.org/about-us/news-and-updates/coronavirus-and-arthritis-what-you-need-to-know
- COVID-19 FAQs: Infection Risk and Prevention — Arthritis Foundation. N/A. https://www.arthritis.org/health-wellness/about-arthritis/related-conditions/other-diseases/covid-19-faqs-infection-risk-and-prevention
- COVID-19 FAQs: Juvenile Arthritis — Arthritis Foundation. N/A. https://www.arthritis.org/health-wellness/about-arthritis/related-conditions/other-diseases/covid-19-faqs-juvenile-arthritis
- COVID-19 and OA: Tips for Staying Healthy — Arthritis Foundation. N/A. https://www.arthritis.org/health-wellness/about-arthritis/related-conditions/other-diseases/covid-19-and-oa-tips
Similar Articles
Read full bio of Sneha Tete
